Howard Marks: Tariffs, Turmoil, and Where to Find Opportunities

Johnny HopkinsHoward Marks1 Comment

Howard Marks’ latest memo, “Nobody Knows (Yet Again),” is a stark reminder of how unpredictable the world—especially the economy—can be. Drawing parallels to the 2008 financial crisis and the COVID-19 pandemic, Marks emphasizes that certainty is a luxury we rarely have, especially during upheavals. “There’s absolutely no place for certainty … Read More

10 Worst Performing Large-Caps Last 12 Months

Johnny HopkinsUnderperforming StocksLeave a Comment

Over the past twelve months ten Large-Cap stocks have underperformed all others. Here’s this week’s top 10 worst performing Large-Caps in the last twelve months: Name 1 Year Price Returns (Daily) Moderna (MRNA) -77.11% Estee Lauder Companies (EL) -64.40% Super Micro Computer (SMCI) -63.81% Albemarle (ALB) -60.05% Microchip Technology (MCHP) … Read More

This Week’s Acquirer’s Multiple FREE U.S Large-Cap Stock Screener Analysis

Johnny HopkinsFREE U.S Large Cap Stock ScreenerLeave a Comment

This week’s large-cap screener covers a wide array of industries, including energy, finance, homebuilding, automobiles, telecommunications, and consumer retail. Among these, sectors like energy, specialty finance, and consumer cyclicals appear to offer the most compelling value based on the Acquirer’s Multiple (AM), a key metric that identifies undervalued companies. Specialty … Read More

David Abrams: Focus on Multiple Future Paths in Investing

Johnny HopkinsDavid AbramsLeave a Comment

David Abrams, Founder of Abrams Capital and former Baupost Group investor, seldom speaks publicly. In a rare interview with Value Investing with Legends, he shared key principles behind his investing strategy. Investing begins with a simple but critical question: “What’s the risk?” As David Abrams explains, the first step is understanding … Read More

One Stock Superinvestors Are Loading Up On

Johnny HopkinsGuru PortfoliosLeave a Comment

As part of the weekly research here at The Acquirer’s Multiple, we’re always interested in investing gurus who hold the same stocks that appear in our Acquirer’s Multiple Stock Screeners, based on their latest 13Fs. Investors such as Warren Buffett, Joel Greenblatt, Carl Icahn, Prem Watsa, Jeremy Grantham, Seth Klarman, … Read More

Bill Nygren: Finding Value in the Shadows of the “Magnificent Seven”

Johnny HopkinsBill NygrenLeave a Comment

The relentless dominance of tech giants—the so-called “Magnificent Seven”—has left many solid companies trading at bargain valuations, creating what veteran investor Bill Nygren calls “an unusual opportunity.” In his recent CNBC interview, the Oakmark Fund portfolio manager highlighted overlooked stocks with single-digit P/E ratios, arguing that the market’s fixation on … Read More

Howard Marks on Tariffs, Market Risks & Opportunities

Johnny HopkinsHoward MarksLeave a Comment

Howard Marks has navigated market cycles for decades, but his recent Bloomberg interview revealed even he finds today’s environment extraordinary. “This is the biggest change in the environment that I’ve seen probably in my career,” he says. The rapid shift from globalization to trade wars and tariffs has created unprecedented … Read More

This Week’s Acquirer’s Multiple FREE U.S Large-Cap Stock Screener Analysis

Johnny HopkinsFREE U.S Large Cap Stock ScreenerLeave a Comment

This Week’s Large-Cap Value Screener This week’s screener highlights a broad mix of sectors, ranging from Integrated Oil and Gas Exploration and Production, Computer Hardware and Storage, Telecommunications Services, Specialty Finance and Energy Utilities. With market volatility still elevated, we’re seeing some standout opportunities in companies with low Acquirer’s Multiples, … Read More

10 Worst Performing Large-Caps Last 12 Months

Johnny HopkinsUnderperforming StocksLeave a Comment

Over the past twelve months ten Large-Cap stocks have underperformed all others. Here’s this week’s top 10 worst performing Large-Caps in the last twelve months: Name 1 Year Price Returns (Daily) Moderna (MRNA) -73.63% Super Micro Computer (SMCI) -64.05% Estee Lauder Companies (EL) -54.12% DexCom (DXCM) -50.76% Align Technology (ALGN) … Read More